Lipocalin-type prostaglandin D synthase is not a biomarker of atherosclerotic manifestations

Author： Hosbond Susanne E.   Diederichsen Axel C. P.   Pedersen Lise   Rasmussen Lars M.   Munkholm Henrik   Gerke Oke   Poulsen Tina S.   Mickley Hans  

Publisher： Informa Healthcare

ISSN： 0036-5513

Source： Scandinavian Journal of Clinical and Laboratory Investigation, Vol.74, Iss.3, 2014-04, pp. : 219-227

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Prostaglandin d synthase is a potential novel therapeutic agent for the treatment of gastric carcinomas expressing PPARγ

By  

INTERNATIONAL JOURNAL OF CANCER, Vol. 137, Iss. 5, 2015-09 ,pp. : 1235-1244

John Wiley & Sons Inc

Access to resources Recommend Favorite

Induction of Microsomal Prostaglandin E Synthase-1 in Human Gingival Fibroblasts

By Yucel-Lindberg Tülay   Hallström Therese   Kats Anna   Mustafa Manal   Modéer Thomas  

Inflammation, Vol. 28, Iss. 2, 2004-04 ,pp. : 89-95

Springer Publishing Company

Access to resources Recommend Favorite

Vitamin D as a clinical biomarker in multiple sclerosis

By Carlson Noel G  

Expert Opinion on Medical Diagnostics, Vol. 7, Iss. 3, 2013-05 ,pp. : 231-242

Informa Healthcare

Access to resources Recommend Favorite

A case of pachyonychia congenita with unusual manifestations: an unusual type or a new syndrome?

By  

INTERNATIONAL JOURNAL OF DERMATOLOGY, Vol. 54, Iss. 3, 2015-03 ,pp. : 334-337

John Wiley & Sons Inc

Access to resources Recommend Favorite

Eosinophil Activation by Prostaglandin D2 and Its Modulation by Seratrodast

By  

International Archives of Allergy and Immunology, Vol. 124, Iss. 1-3, 2012-01 ,pp. : 365-366

Karger

Access to resources Recommend Favorite